-
Je něco špatně v tomto záznamu ?
First experiences with Miethke M.blue® valve in iNPH patients
P. Skalický, A. Mládek, A. Vlasák, H. Whitley, O. Bradáč
Jazyk angličtina
Typ dokumentu časopisecké články
- MeSH
- gravitace MeSH
- lidé MeSH
- následné studie MeSH
- normotenzní hydrocefalus * diagnóza chirurgie MeSH
- ventrikuloperitoneální zkrat metody MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
The literature on hydrocephalus treatment shows support for adjustable valves and devices which prevent the so-called "siphon effect". In our study, 21 probable iNPH patients were indicated to shunt surgery with the Miethke M.blue® adjustable gravitational valve. Outcomes at three months were measured using the following tests: Dutch Gait Scale, International Consortium on Incontinence Questionnaire (ICIQ-UI SF), SF12V2-Health Survey, Kiefer Scale, 3T MRI, and a neuropsychological testing battery. Preoperative parameters were studied for any signs of overdrainage risk. Valves were set according to the manufacturer's recommendations. Significant improvement at three months was seen in the Dutch Gait Scale, ICIQ-UI SF, Kiefer Scale, Mental Health Component of the SF12V2-Health Survey (MCS-12) and three neuropsychological tests: Rey-Osterrieth complex figure test (ROCFT 30 min), auditory verbal learning test (AVLT I-V) and the NKP version of verbal fluency test. Seven patients needed more than one adjustment of the valve. This subgroup significantly improved only in Walking Score and Step Score but the trend was toward significant improvement in other variables. Eight patients had subdural effusions that were completely managed with adjustments until the 3-month control. BMI was significantly lower in patients with ≥2 adjustments compared to those with a maximum of one adjustment. Implantation had low complication rates and no mortality. Initial results are promising however more studies are needed to provide rationale for gravitational valves in iNPH. We recommend increasing the initial valve setting by 2-4 cm H2O above manufacturer's recommendation, especially in lean patients.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018993
- 003
- CZ-PrNML
- 005
- 20220804135242.0
- 007
- ta
- 008
- 220720s2022 stk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jocn.2022.02.004 $2 doi
- 035 __
- $a (PubMed)35180501
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a stk
- 100 1_
- $a Skalický, Petr $u Department of Neurosurgery and Neurooncology, 1st Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 245 10
- $a First experiences with Miethke M.blue® valve in iNPH patients / $c P. Skalický, A. Mládek, A. Vlasák, H. Whitley, O. Bradáč
- 520 9_
- $a The literature on hydrocephalus treatment shows support for adjustable valves and devices which prevent the so-called "siphon effect". In our study, 21 probable iNPH patients were indicated to shunt surgery with the Miethke M.blue® adjustable gravitational valve. Outcomes at three months were measured using the following tests: Dutch Gait Scale, International Consortium on Incontinence Questionnaire (ICIQ-UI SF), SF12V2-Health Survey, Kiefer Scale, 3T MRI, and a neuropsychological testing battery. Preoperative parameters were studied for any signs of overdrainage risk. Valves were set according to the manufacturer's recommendations. Significant improvement at three months was seen in the Dutch Gait Scale, ICIQ-UI SF, Kiefer Scale, Mental Health Component of the SF12V2-Health Survey (MCS-12) and three neuropsychological tests: Rey-Osterrieth complex figure test (ROCFT 30 min), auditory verbal learning test (AVLT I-V) and the NKP version of verbal fluency test. Seven patients needed more than one adjustment of the valve. This subgroup significantly improved only in Walking Score and Step Score but the trend was toward significant improvement in other variables. Eight patients had subdural effusions that were completely managed with adjustments until the 3-month control. BMI was significantly lower in patients with ≥2 adjustments compared to those with a maximum of one adjustment. Implantation had low complication rates and no mortality. Initial results are promising however more studies are needed to provide rationale for gravitational valves in iNPH. We recommend increasing the initial valve setting by 2-4 cm H2O above manufacturer's recommendation, especially in lean patients.
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a gravitace $7 D006112
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a normotenzní hydrocefalus $x diagnóza $x chirurgie $7 D006850
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a ventrikuloperitoneální zkrat $x metody $7 D017287
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mládek, Arnošt $u Department of Neurosurgery and Neurooncology, 1st Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; Department of Cognitive Systems and Neurosciences, Czech Institute of Informatics, Robotics and Cybernetics, Czech Technical University, Prague, Czech Republic
- 700 1_
- $a Vlasák, Aleš $u Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Whitley, Helen $u Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Bradáč, Ondřej $u Department of Neurosurgery and Neurooncology, 1st Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. Electronic address: ondrej.bradac@uvn.cz
- 773 0_
- $w MED00166944 $t Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia $x 1532-2653 $g Roč. 98, č. - (2022), s. 127-132
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35180501 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135235 $b ABA008
- 999 __
- $a ok $b bmc $g 1822549 $s 1170236
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 98 $c - $d 127-132 $e 20220215 $i 1532-2653 $m Journal of clinical neuroscience $n J. clin. neurosci. $x MED00166944
- LZP __
- $a Pubmed-20220720